MELBOURNE, Australia and INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces two additional Non-Executive Director (NED) appointments, effective May 11, 20261, as part of Board expansion and succession planning:
San Diego, CA -- (SBWIRE) -- 04/22/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Avient Corporation.
